Yasmin Zahra

Yasmin Zahra

Auto-generated profile, based on publicly available information

Yasmin Zahra

Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, FL 32224 USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2022 in Science Advances
Verified
Journal Article
Open access
PRPradipta Ranjan Rauta
Pradipta Ranjan Rauta
YMYuri Mackeyev
Yuri Mackeyev
KSKeith Sanders
Keith Sanders
JKJoseph B.K. Kim
Joseph B.K. Kim
VGValeria V. Gonzalez
Valeria V. Gonzalez
SKSunil Krishnan
Sunil Krishnan
Coating nanoparticles with stealth epilayers increases circulation time by evading opsonization, macrophage phagocytosis, and reticuloendothelial sequestration. However, this also reduces internalization by cancer cells upon reaching the tumor. We designed gold nanorods (GNRs) with an epilayer that retains stealth properties in circulation but transforms spontaneously in the acidotic tumor microenvironment to a cell-penetrating particle. We used a customized stoichiometric ratio ofl-glutamic acid andl-lysine within an amphiphilic polymer of poly(l-glutamic acid-co-l-lysine), or P(Glu-co-Lys), to effect this transformation in acidotic environments. P(Glu-co-Lys)-GNRs were internalized by cancer cells to facilitate potent in vitro radiosensitization. When administered intravenously in mice, they accumulate in the periphery and core of tumors without any signs of serum biochemical or hematological alterations, normal organ histopathological abnormalities, or overt deterioration in animal health. Furthermore, P(Glu-co-Lys)-GNRs penetrated the tumor microenvironment to accumulate in the hypoxic cores of tumors to potently radiosensitize heterotopic and orthotopic pancreatic cancers in vivo.

1 November 2022 in Biomaterials
Verified
Journal Article
Closed access
SRSubhiksha Raghuram
Subhiksha Raghuram
YMYuri Mackeyev
Yuri Mackeyev
JSJessica Symons
Jessica Symons
YZYasmin Zahra
Yasmin Zahra
VGValeria Gonzalez
Valeria Gonzalez
SKSunil Krishnan
Sunil Krishnan

28 March 2025 in Science Advances
Verified
Journal Article
Open access
OSOnur Sahin
Onur Sahin
YMYuri Mackeyev
Yuri Mackeyev
GVGeraldine V. Vijay
Geraldine V. Vijay
SRSoumyabrata Roy
Soumyabrata Roy
Ashok Kumar MeiyazhaganAshok Kumar Meiyazhagan
Ashok Kumar Meiyazhagan
SKSunil Krishnan
Sunil Krishnan
Inadequate light penetration in tissues restricts photodynamic therapy to treating only superficial tumors. To enable x-ray–excited photodynamic therapy (XPDT) that targets deep-seated tumors, we synthesized a nanoscintillator-photosensitizer complex containing 5% Eu-doped Y 2 O 3 fluorescing at 611 nanometers and decorated with SiO 2 containing the scintillation-coupled photosensitizer methylene blue and a polyethylene glycol coating [PEGylated Y 2 O 3 :Eu@SiO 2 -methylene blue (pYSM)]. When irradiated, pYSMs generate singlet oxygen species in vitro, causing cytotoxicity with hallmarks of immunogenic cell death (calreticulin translocation to the cell membrane). Intravenously administered pYSMs home passively to pancreatic tumor xenografts and, upon 10 gray irradiation, cause significant tumor regression ( P < 0.01). On combining XPDT with anti-PD1 immunotherapy, a distant nonirradiated tumor also regresses via an increase in intratumoral activated CD8 + cytotoxic T cells. Collectively, we advance a systemically delivered XPDT strategy that mediates an antitumor effect in both irradiated and nonirradiated (abscopal) tumors when coupled with immunotherapy, converting an immunologically “cold” tumor to an immunologically “hot” tumor.